Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
J Appl Res Intellect Disabil ; 32(6): 1389-1400, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31192534

RESUMEN

BACKGROUND: Antipsychotic medications are used among 19%-58% of adults with intellectual disabilities to manage challenging behaviour against the NICE guideline recommendations. Studies show that it is possible to completely withdraw antipsychotics in about one third of adults with intellectual disabilities and a dose reduction of 50% or more in another third. METHOD: In Cornwall, over three years the present authors developed a structured pathway to withdraw antipsychotics among adults with intellectual disabilities which involved people with intellectual disabilities and their carers, GPs, community learning disability team members and pharmacists. RESULTS: The present authors managed to withdraw antipsychotics totally among 46.5% (33/71) and reduced over 50% of dosage in another 11.3% (8/71) of adults with intellectual disabilities. At three months follow-up no one required hospital admission or change in placement. CONCLUSION: It is possible to withdraw/reduce antipsychotics in a high proportion of adults with intellectual disabilities if a concerted effort is made involving all stakeholders from the outset.


Asunto(s)
Antipsicóticos/uso terapéutico , Deprescripciones , Discapacidad Intelectual/tratamiento farmacológico , Uso Excesivo de los Servicios de Salud/prevención & control , Problema de Conducta , Inglaterra , Médicos Generales , Humanos , Grupo de Atención al Paciente , Guías de Práctica Clínica como Asunto , Desarrollo de Programa , Evaluación de Programas y Proyectos de Salud , Participación de los Interesados
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda